Background: Acute bronchiolitis is a common cause of pediatric emergency department admissions in children younger than 2. Objectives: The study aimed to compare the outcomes and the severity of bronchiolitis in young children with multiple simultaneous respiratory virus infections to those with single virus infection and no virus identified group. Methods: Patients with moderate and severe bronchiolitis who visited our emergency department between November 2016 and May 2017 had nasopharyngeal swab samples results tested by multiplex polymerase chain reaction were included in the study. Patients' characteristics, clinical severity of illness, and outcome (pediatric emergency department discharge, admission to ward or pediatric intensive care unit) were compared with the detected viral agents. Results: A total of 241 patients were included in the study. The mean age was 7.8 ± 2.6 months and 147 (61%) were male. Respiratory syncytial virus was the most common detected viral agent in 108 (39%) cases followed by human rhinoviruses in 67 (24%). Respiratory syncytial virus was found more frequently in February and March (p = 0.002). Leukocytosis and pneumonia were more likely observed in patients with only human rhinoviruses (+) subjects (p = 0.010 and p = 0.015, respectively). Intensive care hospitalization rate (16%) was higher in patients with multiple viral agents (p = 0.004). Conclusions: Respiratory syncytial virus remains the most common detected viral agent in acute bronchiolitis patients. While the pathogens detected were seasonally different, there was a significant relationship between leukocytosis, bacterial pneumonia, and detected viral agents. The disease was more severe in patients with multiple viral agents.
Introduction
Acute bronchiolitis (AB) is a lower respiratory tract infection (RTI) most commonly seen between 0 and 2 years and that generally manifests with wheezing, tachypnea, and intercostal, subcostal, or suprasternal retractions. The disease is diagnosed by physical examination and commonly a mild self-limited respiratory illness in infants. Although respiratory failure is a uncommon condition in the course of AB, it sometimes requires intubation and mechanical ventilation. 1 Underlying diseases or clinical conditions such as immune deficiency, cardiac disease, chronic pulmonary disease, and prematurity are implicated in the severe nature of the condition, with the causative pathogen also being involved. 2 Viral pathogens are generally responsible for AB. The most commonly identified agents are viruses such as "respiratory syncytial virus" (RSV), "human rhinovirus" (HRV), "parainfluenza virus" (PIV), "influenza virus" (INF), "human metapneumovirus" (hMPV), "adenovirus" (AdV), "human bocavirus" (HBoV), "human coronavirus" (HCoV), and "enteroviruses" (EV). 3 Since patients infected with different respiratory viruses exhibit the same clinical findings, the etiological agent can only be specifically identified through laboratory tests. Viral pathogens can be identified quickly from nasopharyngeal swab (NPS) specimens using the polymerase chain reaction (PCR) method. 4 The entry into use of multiplex PCR (m-PCR) methods capable of identifying large numbers of respiratory viruses in a single specimen has been of particular benefit in determining viral co-infections. 5, 6 The type of pathogen determined is reported to create variation in predicting a severe course of disease. The presence of more than one virus has also been reported to cause significant variation. 7 Investigation of the viral pathogen in AB is extremely important in preventing unnecessary antibiotic use and in terms of antiviral therapy or inoculation for selected patients. In addition, since AB is the most common cause of hospitalization in young infants (<12 months), a good understanding of its viral etiology and immunology can contribute to the follow-up and treatment of the disease and thus reduce total hospitalization rates in children. 8 The purpose of our study was to determine the viral agent in patients who had AB and observed at the short stay unit in the pediatric emergency department (PED), and to investigate the effect of the viral agent(s) on the severity of the disease.
Methods

Study period and population
This study was conducted at the Emergency Department of Ege University Children's Hospital, Izmir, Turkey. In Izmir, which is the third biggest city in Turkey on the Aegean Sea, the climate is Mediterranean, with relatively mild winters, and hot and sunny summers. A total of 41,000 patients presented to the PED during the study period (November 2016-May 2017). Children who had nasal obstruction, fever, cough, and wheezing were examined, and the examination revealed that tachypnea, wheezing, rales, and rhonchus were assessed as AB. Only 2108 patients had bronchiolitis, and 274 were classified as moderate or severe. In our ED, we use the clinical score which was created by Liu et al.; 9 in this score, four clinical parameters were selected: respiratory rate, retractions, dyspnea, and auscultation.
We excluded 33 patients due to lack of NPS specimens studied or missing data. Eventually, 241 patients were included in the study. Ten of the 33 excluded patients discharged from the ED after management, remaining 23 admitted to the general pediatric ward.
Data collection
Only children with a first or second wheezing episode who classified as moderate or severe bronchiolitis were enrolled. Patients with three or more AB episodes and/or with congenital heart disease, cystic fibrosis, neuromuscular disease, bronchopulmonary dysplasia, or immune deficiency were excluded. Cases' demographic, clinical, and laboratory characteristics; age, sex, readmission to the ED within 24 h, prematurity, underlying disease, additional infection (pneumonia, otitis, and upper airway infection), antibiotic use, administration of invasive or non-invasive ventilation, body temperature, complete blood count (CBC), C-reactive protein (CRP), biochemical parameters, and chest x-ray; and the results of these if applicable, were investigated retrospectively from PED medical records. The follow-up of study patients after discharge (hospitalization rate, ward, pediatric intensive care unit (PICU)) and NPS results were also reviewed.
NPS specimens were sent to the laboratory inside viral transport media (UTM, Copan Diagnostics, Italy) following cold chain procedures. Specimens arriving at the laboratory and not tested immediately were stored at −80°C. Respiratory viruses and subtypes of these viruses in clinical specimens were identified using multiplex real-time PCR (Allplex Respiratory Full Panel, Seegene, South Korea). Following nucleic acid extraction (RibospinvRD viral RNA/DNA Extraction Kit, GeneAll, Seegene, South Korea) amplification was performed with dual priming oligonucleotide primers specific to respiratory viruses (INF-A, INF-B, RSV A&B, AdV, hMPV, HCoV(229E, NL63, OC43), PIV tip 1-4, HRV A/B/C, EV, HBoV1/2/3/4) using probes and single-step enzymes in line with the manufacturer's instructions. PCR products were determined using the "CFX96TM Real-time PCR System" (Bio-Rad). Internal, negative and positive controls were used in each test from the extraction stage onward. The method used was tested at least twice a year in routine application using "UK Nequas, Virus identification" external quality control software.
Cases were divided into six groups in order to establish relations between the viral agents identified and clinical manifestations. Six groups consisting of the three most commonly determined single agents, other single agents, multiple agents, and no agent determined groups were established, and the effect of these on disease severity was evaluated. Prognostic criteria were determined as discharge from the PED, and admission to the pediatric ward or PICU.
Statistical analysis
Statistical analyses were performed on SPSS v.21 software. In addition to descriptive statistical methods (mean, standard deviation, median, and interquartile range), qualitative data were compared between groups using Pearson's chisquare test (if n value < 5, Fisher's exact test preferred) and one-way analysis of variance (ANOVA). Student's t test was used to compare normally distributed numerical data and the Mann-Whitney U test to compare non-normally distributed data. Odds ratio (OR) values were obtained using logistic regression analysis. Results were considered significant at p < 0.05 at a 95% confidence interval.
Ethical approval
The study commenced following receipt of ethical approval from the local Ethical Committee in 2017.
Results
Two hundred forty-one patients with moderate or severe bronchiolitis who had result of NPS analyzed by m-PCR were included in the study. The mean age of the patients enrolled was 7.8 ± 2.6 months, and 147 (61%) were boys. One hundred nine (45%) patients were younger than 6 months. Most patients received chest x-ray, CBC, CRP, and other biochemical parameters (87%), only chest x-ray obtained for 7 (3%), no tests performed for 23 (10%) patients. Prematurity was present in 44 (18%) of all patients, elevated body temperature in 62 (28%), leukocytosis in 59 (24%), and eosinophilia in 28 (12%). Acute otitis media (AOM) secondary to existing disease was determined in 51 cases (21%), while 14 (6%) patients were diagnosed with pneumonia and 7 (3%) with urinary tract infection (UTI). Invasive and/or non-invasive ventilation was performed to 23 (9.5%) patients. One fifth of patients were discharged from the PED, 179 (74.3%) were admitted to the pediatric ward and 13(5.4%) to the PICU. Patients' demographic, clinical, and laboratory characteristics are shown in Table 1 .
At least one viral agent (with a total of 277 viruses) was determined in majority of patients (87%).
A single viral pathogen was determined in 154 (64%) of cases and multiple viral agents in 56 (23%) (two agents in 45 (19%) and three in 11 (4%)). At analysis of the single and multiple agents, RSV A-B was the most common identified agent in 108 (39%) cases, followed by HRV in 67 (24%) and hMPV in 26 (10%) ( Table 2 ). RSV and/or HRV were determined in 159 (58%) cases, while the most common combination in multiple agent group was RSV + HRV (n = 16, 29%).
The monthly and seasonal distribution of viral agents showed that incidence of RSV infection peaked during February and March, whereas HRV peaked during November (p = 0.002). The rate of hospitalization to the PICU was higher in patients infected with multiple viral agents (16%) (p = 0.004). When compared with non-HRV viruses, patients with isolated only HRV were more likely to have leukocytosis (47%) and pneumonia (19%) (p = 0.010 and p = 0.015, respectively). (Table 3) .
Associating factors of the admission to the PICU were evaluated by logistic regression analysis. Leukocytosis and/or neutrophilia influenced hospitalization to the PICU. The most effective factor was the presence of multiple viral agent on NPS (Table 4) .
All patients discharged, and no fatal complications developed in any case. 
Discussion
This study examined patients with moderate and severe AB presenting to a tertiary emergency department over one spring/winter season. Their NPS specimens studied via m-PCR method. While, RSV is still the most common detected viral agent in patients with AB, HRV is the second most widely determined agent. [10] [11] [12] [13] [14] [15] Similarly in our study at least one viral pathogen was determined in 87%, the most common virus was RSV, followed by HRV. It is known that viral RTIs have a seasonal character, particularly in regions with temperate climates, and the peak periods may change from year to year. In many studies, respiratory viruses have been reported to be active during winter (generally from November to March) in the Northern Hemisphere. 16, 17 In a study from Lebanon, Finianos et al. 18 observed that RSV reached a peak in December and January, while HRV peaked in February. Similarly in our study, RSV was particularly prevalent in February and March.
Although AB does not increase the risk for serious bacterial infection, occasionally concomitant or secondary bacterial infections may occur. Of the respiratory viral infections, RSV infection seems to be the one most commonly accompanied by AOM. 19, 20 In our group, the most common concomitant infection was also found as AOM.
Previous studies demonstrated that in AB, multiple viral pathogens can be detected between 9% and 44%. 21, 22 In two prospective, multi-center study of patients with bronchiolitis presenting to the PED, the multiple viral pathogens detection rate reported as 22.5% and 28% and RSV + HRV combination was the most prevalent group. 23, 24 Similarly in the present study, we determined multiple viral agents as 23%, and the most prevalent combination is RSV + HRV.
Since HRV is one of the most frequently determined agents in patients with AB, it is also the most widely studied pathogen. 25 In this study, we found that, the detection of HRV by PCR was associated with increase in the frequency of leukocytosis and pneumonia compared with infants with no virus detected/other groups. Calvo et al. 26 (7) 6 (21) 9 (31) 3 (10) January 14 (22) 14 (22) 7 (11) 7 (11) 16 (25) 6 (9) February 29 (39) 10 (13) 5 (6) 11 (14) 14 (18) 8 (10) March 16 (35) 2 (5) 1 (2) 3 (7) 10 (23) 12 ( (14) 1 (7) 2 (14) Prematurity (+)
11 (15) 7 (19) 5 (30) 2 (7) 13 (23) 6 (19) 0.336 Temperature >37.5°C
16 (22) 9 (24) 5 (31) 10 (35) 13 (23) 9 (29) 0.809 Laboratory-examined (+)
64 (89) 35 (95) 12 (75) 27 (93) 52 (93) 28 (90) 0.309 Leucocytosis >15,000/mm 3 8 (13) 16 (47) 2 (14) 7 (26) 17 (33) 9 (32) 0.010* ANC >10,000/mm 3 6 (10) 11 (32) 2 (14) 8 (30) 12 (23) 5 (18) 0.099 Eosinophilia >400/mm 3 7 (12) 8 (24) 1 (7) 4 (15) 5 (10) 3 (11) 0.463 CRP >2 mg/dL, n (%)
17 (28) 13 (38) investigated more than 2500 cases, and determined higher leukocytosis rates and CRP elevation in patients with HRV, and reported that these patients were more frequently diagnosed with bacterial pneumonia and received antibiotics more frequently. The detection of multiple co-incident viruses in clinical settings is becoming more common since the introduction of molecular-based multiplex PCR tests, but the clinical significance of these remains unclear. The impact of these on the disease severity is controversial. While some publications have reported that the presence of multiple viral agents exacerbates the clinical course in AB patients, others have reported that they had no impact on the disease severity. 27, 28 Brand et al. 29 reported that the presence of multiple viral agents does not have an effect on clinical progression in AB. In contrast, another study from Austria conducted with a larger number of patients reported that the presence of multiple viral agents resulted in a more severe clinical course. 30 Co-infected children with multiple viral agents in our study were almost more likely to be admitted to the PICU than those with single viral infections. Compared to our study, Brand et al. developed a study with a small sample size in a small region.
The main limitations of our study are that it reflects the experience of a single center, is retrospective, and involves a single season.
In conclusion, the most commonly identified agent was RSV, followed by HRV and HMPV. The severity and course of an AB episode requiring PICU in children was correlated with the presence of more than one virus on NPS. The most common bacterial infection in AB patients was AOM. The detection of HRV changes the likelihood of leukocytosis and pneumonia in infants with bronchiolitis. Future studies are needed to investigate whether particular viruses, or combinations of viruses, influence the risk of bacterial coinfection, hospitalization, and disease severity. E.U.S. wrote the manuscript; A.Y., C.Ç., and E.U.S. made the critical revision of this manuscript. All authors read and approved the final manuscript.
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